1. Home
  2. VBIX vs FGEN Comparison

VBIX vs FGEN Comparison

Compare VBIX & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBIX
  • FGEN
  • Stock Information
  • Founded
  • VBIX N/A
  • FGEN 1993
  • Country
  • VBIX Israel
  • FGEN United States
  • Employees
  • VBIX N/A
  • FGEN N/A
  • Industry
  • VBIX Computer Software: Prepackaged Software
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VBIX Technology
  • FGEN Health Care
  • Exchange
  • VBIX Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • VBIX 26.4M
  • FGEN 33.5M
  • IPO Year
  • VBIX N/A
  • FGEN 2014
  • Fundamental
  • Price
  • VBIX $5.27
  • FGEN $7.03
  • Analyst Decision
  • VBIX
  • FGEN Strong Buy
  • Analyst Count
  • VBIX 0
  • FGEN 1
  • Target Price
  • VBIX N/A
  • FGEN $250.00
  • AVG Volume (30 Days)
  • VBIX 111.2K
  • FGEN 43.0K
  • Earning Date
  • VBIX 08-14-2025
  • FGEN 08-12-2025
  • Dividend Yield
  • VBIX N/A
  • FGEN N/A
  • EPS Growth
  • VBIX N/A
  • FGEN N/A
  • EPS
  • VBIX N/A
  • FGEN N/A
  • Revenue
  • VBIX $19,672,000.00
  • FGEN $6,996,000.00
  • Revenue This Year
  • VBIX N/A
  • FGEN N/A
  • Revenue Next Year
  • VBIX N/A
  • FGEN N/A
  • P/E Ratio
  • VBIX N/A
  • FGEN N/A
  • Revenue Growth
  • VBIX N/A
  • FGEN N/A
  • 52 Week Low
  • VBIX $2.42
  • FGEN $4.50
  • 52 Week High
  • VBIX $12.00
  • FGEN $29.00
  • Technical
  • Relative Strength Index (RSI)
  • VBIX N/A
  • FGEN 50.17
  • Support Level
  • VBIX N/A
  • FGEN $7.04
  • Resistance Level
  • VBIX N/A
  • FGEN $7.56
  • Average True Range (ATR)
  • VBIX 0.00
  • FGEN 0.49
  • MACD
  • VBIX 0.00
  • FGEN -0.00
  • Stochastic Oscillator
  • VBIX 0.00
  • FGEN 12.53

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: